Navigation Links
IS Clinical Launches New ADVANCE+ Skincare Line
Date:6/19/2008

Offers phenomenal breakthrough in Vitamin C formulation technology seen in

over a decade

Available Globally in July 2008

NEW YORK, June 19 /PRNewswire/ -- IS Clinical, an exclusive skincare brand by INNOVATIVE SKINCARE, has raised the bar once again in formulation and ingredient technology with the highly-effective, clinically-validated skincare line: ADVANCE+.

The Innovative Skincare R&D team sourced a new version of L-Ascorbic Acid (Vitamin C) technology to employ in the ADVANCE+ formulas. This version of L-Ascorbic Acid offers time-released, continuous and steady delivery to cells, providing a more efficient and effective form of the powerhouse ingredient. Additionally, its uniquely stabilized molecular structure allows it to be formulated with other potent ingredients, previously thought impossible, to enable enhanced collagen production and additional anti-aging benefits.

Innovative Skincare's expert team of PhDs, under the direction of Medical Director Charlene DeHaven, MD, FACEP, directed the development of the line from concept to market, including: sourcing the ingredients worldwide and coordinated independent clinical testing on all formulations for safety and efficacy. In an effort to uphold supreme ethical standards and adhere to strict medical guidelines, Innovative Skincare is moving forward without the involvement of former R&D team member Dr. Mostafa Omar, and by extension Phytoceuticals, Inc.

The new ADVANCE+ line includes: Super Serum ADVANCE+, Pro-Heal Serum ADVANCE+, and C Eye ADVANCE+ and will launch globally in July 2008.

IS Clinical products are exclusively sold through dermatologists, plastic surgeons, medi-spas, and luxury professional skincare locations. To find a retailer near you, log on to http://www.innovativeskincare.com.

IS Clinical is the exclusive skincare brand by INNOV
'/>"/>

SOURCE IS Clinical
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PAREXEL Expands Global Clinical Logistics Capabilities
2. Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and Data Management
3. Campbell Alliance Clinical Development Practice to Conduct Two Workshops at 44th DIA Annual Meeting
4. PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
5. Positive clinical data for PBI-1402 presented at the Annual Congress of the European Hematology Association
6. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
7. Cardium Launches New AWARE Clinical Study Website
8. Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)
9. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
10. Texas Oncology-Baylor Sammons Cancer Center Recognized for Highest Commitment to Clinical Research at ASCO
11. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... 26, 2015  Platform therapeutic company Symic Biomedical, ... a $1.5M Phase II SBIR grant from the ... its therapeutic agent to reduce arteriovenous fistula (AVF) ... stage renal disease (ESRD) patients undergoing hemodialysis. The ... Diabetes and Digestive and Kidney Diseases (NIDDK), will ...
(Date:8/26/2015)... BEIJING , August 26, 2015 Israel ... DiaCardio wins 1 st place  Wayerz comes ... in Israel by venture capital fund JVP, ... including the US, China , Israel ... America .  Impressive achievement for the Israeli representatives ...
(Date:8/26/2015)... 26, 2015 After litigating and negotiating ... relating to P2i United States patent ... in the United States without any ... of either party. As a result of the parties, settlement, ... California dismissed the case without prejudice. ...
(Date:8/26/2015)... ... August 26, 2015 , ... PRC Clinical, a Clinical Trial ... with local sponsors in southern California. The Clinical Trial Management Expert CRO seeks to ... regulatory pathways., , Stem Cell Meeting on the Mesa ...
Breaking Biology Technology:Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6P2i Settles United States Litigation 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3
... Webcast to Be Held Today at 5:00 p.m. ET (22:00 CET), 2007 ... - Naglazyme net product revenue of $86.2 million, an increase of ... range of $82 million to $84 million, ... 28.5 percent over 2006 and toward the upper ...
... Recommend Pharmion ... with Celgene Special Meeting of ... Urges All Shareholders to Vote FOR the Proposed Merger, ... today announced that Institutional Shareholder Services,(ISS) has recommended that Pharmion ...
... in February issue of Clinical and Vaccine Immunology, ... and the University of Michigan have demonstrated their nasally,delivered ... lethal dose of smallpox, and without the safety risks ... smallpox virus,and builds immunity against it., The new ...
Cached Biology Technology:BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 2BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 3BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 4BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 5BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 6BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 7BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 8BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 9BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 10BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results 11ISS Recommends Pharmion Shareholders Vote for Merger With Celgene 2ISS Recommends Pharmion Shareholders Vote for Merger With Celgene 3Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 2Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 3
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
(Date:8/12/2015)... Aug. 12, 2015  New research unveiled at ... Android phones to steal users, fingerprints. Information released ... of fingerprint scanners on mobile devices, making the ... secure biometrics on mobile devices, HYPR Corp. recently ... convenient authentication systems with strong cryptographic security. More ...
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
... fond of talking about it as are politicians, economists ... The problem is that the term sustainability can refer ... at the Technische Universitaet Muenchen have shed light on ... science they have managed to give the term "sustainability" ...
... School of Medicine found that women may have a slightly higher ... acute coronary syndrome (ACS), but that these differences appear to be ... study, published in the August 26, 2009 issue of the ... however that overall there was no significant difference in mortality observed ...
... use wireless sensors, which can monitor chemical processes or ... wireless network. Still, many facilities that could benefit ... use a wired network instead, because the reliability, speed ... do not meet their needs. The U.S. ...
Cached Biology News:New tools for sustainable farming 2New tools for sustainable farming 3Study finds women slightly more likely to die than men in the 30 days following a heart attack 2SRNL, automakers to develop high-performance wireless sensors networks 2SRNL, automakers to develop high-performance wireless sensors networks 3
... These handy dispensers save space ... wipers, hats, and other garb. ... storage bins for small parts ... manufacturing. Clear acrylic. Open-slot design ...
... is critical to the maintenance of ... proteins as important and diverse as ... shock and stress response, antigen presentation, ... ion channels, cell cycle regulation, transcription, ...
... The LIBS-ELITE houses Ocean Optics LIBS2000+ Spectrometers ... Universal Platform (UP) Ablation Chamber to offer ... control. The systems features include a high-power ... targeting functions, precise X-Y sample positioning, laser ...
... whole-blood clinical diagnostic work in hospitals and ... analyzer makes precise glucose measurements of whole ... measurements of whole blood, plasma, or cerebrospinal ... you to have glucose results expressed as ...
Biology Products: